Private Company

Company Overview

Havn is a biotechnology company aimed at improving cognitive performance through the standardized extraction of psychoactive compounds and the development of natural health care products from novel compounds. 

With a research lab and offices located in the South Research Campus of The University of British Columbia and a team of scientists with extensive experience in chemistry and formulation development, the company is dedicated to helping people operate at peak mental performance and experience a considerable reduction in symptoms associated with mental illness.

Management Team

Susan Chapelle

Tim Moore

Dr. Ivan Casselman
Chief Psychedelics Officer

Alexzander Samuelsson
Chief Research Officer

Eli Dusenbury

Barinder Rasode
Executive Co-Chair

Robert Nygren
Executive Co-Chair

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.